Epstein Files Full PDF

CLICK HERE
Technopedia Center
PMB University Brochure
Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education
teknopedia

  • Registerasi
  • Brosur UTI
  • Kip Scholarship Information
  • Performance
Flag Counter
  1. World Encyclopedia
  2. GLUT2 - Wikipedia
GLUT2 - Wikipedia
From Wikipedia, the free encyclopedia
Transmembrane carrier protein

glucose transporter, type 2
Identifiers
Aliases11006, Glc_transpt_2, IPR002440, GLUT2, Glucosamine/glucose uniporter, Glut-2, Glucose Transporter Type 2
External IDsGeneCards: 11006; OMA:11006 - orthologs
Orthologs
SpeciesHumanMouse
Entrez

n/a

n/a

Ensembl

n/a

n/a

UniProt

n
a

n/a

RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human
Glucose transporter 2 (GLUT2) also known as solute carrier family 2, member 2 (SLC2A2) is a transmembrane carrier protein that enables protein facilitated glucose movement across cell membranes
Glut2basal.png

Glucose transporter 2 (GLUT2) also known as solute carrier family 2 (facilitated glucose transporter), member 2 (SLC2A2) is a transmembrane carrier protein that enables protein facilitated glucose movement across cell membranes. It is the principal transporter for transfer of glucose between liver and blood[1] Unlike GLUT4, it does not rely on insulin for facilitated diffusion.

In humans, this protein is encoded by the SLC2A2 gene.[2][3]

Tissue distribution

[edit]

GLUT2 is found in cellular membranes of:

  • liver (Primary)
  • pancreatic β cell (Primary in mice, tertiary in humans after GLUT1 and GLUT3)[4]
  • hypothalamus (Not overly significant)
  • basolateral membrane of small intestine and apical GLUT2 is also suggested.[5]
  • basolateral membrane of renal tubular cells[6][7]

Function

[edit]

GLUT2 has high capacity for glucose but low affinity (high KM, ca. 15–20 mM) and thus functions as part of the "glucose sensor" in the pancreatic β-cells of rodents, though in human β-cells the role of GLUT2 seems to be a minor one.[4] It is a very efficient carrier for glucose.[8][9] Similarly, a recent study showed that lack of GLUT2 in β-cells doesn't impair glucose homeostasis or glucose-stimulated insulin secretion in mice.[10]

GLUT2 also carries glucosamine and fructose.[11]

When the glucose concentration in the lumen of the small intestine goes above 30 mM, such as occurs in the fed-state, GLUT2 is up-regulated at the brush border membrane, enhancing the capacity of glucose transport. Basolateral GLUT2 in enterocytes also aids in the transport of fructose into the bloodstream through glucose-dependent cotransport. Recent studies show that renal GLUT2 contributes to systemic glucose homeostasis by regulating glucose reabsorption.[7] Lack of renal Glut2 reversed features of diabetes and obesity in mice. In addition, renal Glut2 deficiency caused knockdown of renal Sglt2 through the transcription factor Hnf1α.[7]

Clinical significance

[edit]

Defects in the SLC2A2 gene are associated with a particular type of glycogen storage disease called Fanconi-Bickel syndrome.[12]

In drug-treated diabetic pregnancies in which glucose levels in the woman are uncontrolled, neural tube and cardiac defects in the early-developing brain, spine, and heart depend upon functional GLUT2 carriers, and defects in the GLUT2 gene have been shown to be protective against such defects in rats.[13] However, whilst a lack of GLUT2 adaptability[14] is negative, it is important to remember the fact that the main result of untreated gestational diabetes appears to cause babies to be of above-average size, which may well be an advantage that is managed very well with a healthy GLUT2 status.

Maintaining a regulated osmotic balance of sugar concentration between the blood circulation and the interstitial spaces is critical in some cases of edema including cerebral edema.

GLUT2 appears to be particularly important to osmoregulation, and preventing edema-induced stroke, transient ischemic attack or coma, especially when blood glucose concentration is above average.[15] GLUT2 could reasonably be referred to as the "diabetic glucose transporter" or a "stress hyperglycemia glucose transporter."

SLC2A2 was associated with clinical stages and independently associated with overall survival in patients with Hepatocellular carcinoma, and could be considered a new prognostic factor for HCC.[16]

Interactive pathway map

[edit]

Click on genes, proteins and metabolites below to link to respective articles.[§ 1]

[[File:
GlycolysisGluconeogenesis_WP534go to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to WikiPathwaysgo to articlego to Entrezgo to article
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
GlycolysisGluconeogenesis_WP534go to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to WikiPathwaysgo to articlego to Entrezgo to article
]]
Glycolysis and Gluconeogenesis edit
  1. ^ The interactive pathway map can be edited at WikiPathways: "GlycolysisGluconeogenesis_WP534".

See also

[edit]
  • Glucose transporter

References

[edit]
  1. ^ Gould GW, Thomas HM, Jess TJ, Bell GI (May 1991). "Expression of human glucose transporters in Xenopus oocytes: kinetic characterization and substrate specificities of the erythrocyte, liver, and brain isoforms". Biochemistry. 30 (21): 5139–5145. doi:10.1021/bi00235a004. PMID 2036379.
  2. ^ Froguel P, Zouali H, Sun F, Velho G, Fukumoto H, Passa P, et al. (July 1991). "CA repeat polymorphism in the glucose transporter GLUT 2 gene". Nucleic Acids Research. 19 (13): 3754. doi:10.1093/nar/19.13.3754-a. PMC 328421. PMID 1852621.
  3. ^ Uldry M, Thorens B (February 2004). "The SLC2 family of facilitated hexose and polyol transporters" (PDF). Pflügers Archiv. 447 (5): 480–489. doi:10.1007/s00424-003-1085-0. PMID 12750891. S2CID 25539725.
  4. ^ a b McCulloch LJ, van de Bunt M, Braun M, Frayn KN, Clark A, Gloyn AL (December 2011). "GLUT2 (SLC2A2) is not the principal glucose transporter in human pancreatic beta cells: implications for understanding genetic association signals at this locus". Molecular Genetics and Metabolism. 104 (4): 648–653. doi:10.1016/j.ymgme.2011.08.026. PMID 21920790.
  5. ^ Kellett GL, Brot-Laroche E (October 2005). "Apical GLUT2: a major pathway of intestinal sugar absorption". Diabetes. 54 (10): 3056–3062. doi:10.2337/diabetes.54.10.3056. PMID 16186415.
  6. ^ Freitas HS, Schaan BD, Seraphim PM, Nunes MT, Machado UF (June 2005). "Acute and short-term insulin-induced molecular adaptations of GLUT2 gene expression in the renal cortex of diabetic rats". Molecular and Cellular Endocrinology. 237 (1–2): 49–57. doi:10.1016/j.mce.2005.03.005. PMID 15869838. S2CID 44856595.
  7. ^ a b c de Souza Cordeiro LM, Bainbridge L, Devisetty N, McDougal DH, Peters DJ, Chhabra KH (June 2022). "Loss of function of renal Glut2 reverses hyperglycaemia and normalises body weight in mouse models of diabetes and obesity". Diabetologia. 65 (6): 1032–1047. doi:10.1007/s00125-022-05676-8. PMC 9081162. PMID 35290476.
  8. ^ Guillam MT, Hümmler E, Schaerer E, Yeh JI, Birnbaum MJ, Beermann F, et al. (November 1997). "Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2". Nature Genetics. 17 (3): 327–330. doi:10.1038/ng1197-327. PMID 9354799. S2CID 37328600.
  9. ^ Efrat S (November 1997). "Making sense of glucose sensing". Nature Genetics. 17 (3): 249–250. doi:10.1038/ng1197-249. PMID 9354775. S2CID 13219161.
  10. ^ Bathina S, Faniyan TS, Bainbridge L, Davis A, Chhabra KH (March 2023). "Normal β-Cell Glut2 Expression Is not Required for Regulating Glucose-Stimulated Insulin Secretion and Systemic Glucose Homeostasis in Mice". Biomolecules. 13 (3): 540. doi:10.3390/biom13030540. PMC 10046365. PMID 36979475.
  11. ^ Uldry M, Ibberson M, Hosokawa M, Thorens B (July 2002). "GLUT2 is a high affinity glucosamine transporter". FEBS Letters. 524 (1–3): 199–203. Bibcode:2002FEBSL.524..199U. doi:10.1016/S0014-5793(02)03058-2. PMID 12135767. S2CID 40913482.
  12. ^ Santer R, Groth S, Kinner M, Dombrowski A, Berry GT, Brodehl J, et al. (January 2002). "The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome". Human Genetics. 110 (1): 21–29. doi:10.1007/s00439-001-0638-6. PMID 11810292. S2CID 1767168.
  13. ^ Li R, Thorens B, Loeken MR (March 2007). "Expression of the gene encoding the high-Km glucose transporter 2 by the early postimplantation mouse embryo is essential for neural tube defects associated with diabetic embryopathy". Diabetologia. 50 (3): 682–689. doi:10.1007/s00125-006-0579-7. PMID 17235524.
  14. ^ Thomson AB, Wild G (March 1997). "Adaptation of intestinal nutrient transport in health and disease. Part I". Digestive Diseases and Sciences. 42 (3): 453–469. doi:10.1023/A:1018807120691. PMID 9073126. S2CID 25371741.
  15. ^ Stolarczyk E, Le Gall M, Even P, Houllier A, Serradas P, Brot-Laroche E, et al. (December 2007). Maedler K (ed.). "Loss of sugar detection by GLUT2 affects glucose homeostasis in mice". PLOS ONE. 2 (12) e1288. Bibcode:2007PLoSO...2.1288S. doi:10.1371/journal.pone.0001288. PMC 2100167. PMID 18074013. Open access icon
  16. ^ Kim YH, Jeong DC, Pak K, Han ME, Kim JY, Liangwen L, et al. (September 2017). "SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma". Oncotarget. 8 (40): 68381–68392. doi:10.18632/oncotarget.20266. PMC 5620264. PMID 28978124.

External links

[edit]
  • Glucose+Transporter+Type+2 at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
  • v
  • t
  • e
Membrane proteins, carrier proteins: membrane transport proteins solute carrier (TC 2A)
By group
SLC1–10
(1):
  • high affinity glutamate and neutral amino-acid transporter
    • SLC1A1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
(2):
  • facilitative GLUT transporter
    • SLC2A1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
(3):
  • heavy subunits of heterodimeric amino-acid transporters
    • SLC3A1
    • 2
(4):
  • bicarbonate transporter
    • SLC4A1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
(5):
  • sodium glucose cotransporter
    • SLC5A1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
(6):
  • sodium- and chloride- dependent sodium:neurotransmitter symporters
    • SLC6A1
    • SLC6A2
    • SLC6A3
    • SLC6A4
    • SLC6A5
    • SLC6A6
    • SLC6A7
    • SLC6A8
    • SLC6A9
    • SLC6A10
    • SLC6A11
    • SLC6A12
    • SLC6A13
    • SLC6A14
    • SLC6A15
    • SLC6A16
    • SLC6A17
    • SLC6A18
    • SLC6A19
    • SLC6A20
(7):
  • cationic amino-acid transporter/glycoprotein-associated
    • SLC7A1
    • SLC7A2
    • SLC7A3
    • SLC7A4
  • glycoprotein-associated/light or catalytic subunits of heterodimeric amino-acid transporters
    • SLC7A5
    • SLC7A6
    • SLC7A7
    • SLC7A8
    • SLC7A9
    • SLC7A10
    • SLC7A11
    • SLC7A13
    • SLC7A14
(8):
  • Na+/Ca2+ exchanger
    • SLC8A1
    • SLC8A2
    • SLC8A3
(9):
  • Na+/H+ exchanger
    • SLC9A1
    • SLC9A2
    • SLC9A3
    • SLC9A4
    • SLC9A5
    • SLC9A6
    • SLC9A7
    • SLC9A8
    • SLC9A9
    • SLC9A10
    • SLC9A11
(10):
  • sodium bile salt cotransport
    • SLC10A1
    • SLC10A2
    • SLC10A3
    • SLC10A4
    • SLC10A5
    • SLC10A6
    • SLC10A7
  • 10A1
  • 10A2
  • 10A3
  • 10A7
SLC11–20
(11):
  • proton coupled metal ion transporter
    • SLC11A1
    • SLC11A211A3
(12):
  • electroneutral cation-Cl cotransporter
    • SLC12A1
    • SLC12A2
    • SLC12A3
    • SLC12A4
    • SLC12A5
    • SLC12A6
    • SLC12A7
    • SLC12A8
    • SLC12A9
(13):
  • human Na+-sulfate/carboxylate cotransporter
    • SLC13A1
    • SLC13A2
    • SLC13A3
    • SLC13A4
    • SLC13A5
(14):
  • urea transporter
    • SLC14A1
    • SLC14A2
(15):
  • proton oligopeptide cotransporter
    • SLC15A1
    • SLC15A2
    • SLC15A3
    • SLC15A4
(16):
  • monocarboxylate transporter
    • SLC16A1
    • SLC16A2
    • SLC16A3
    • SLC16A4
    • SLC16A5
    • SLC16A6
    • SLC16A7
    • SLC16A8
    • SLC16A9
    • SLC16A10
    • SLC16A11
    • SLC16A12
    • SLC16A13
    • SLC16A14
(17):
  • Vesicular glutamate transporter 1
    • SLC17A1
    • SLC17A2
    • SLC17A3
    • SLC17A4
    • SLC17A5
    • SLC17A6
    • SLC17A7
    • SLC17A8
    • SLC17A9
(18):
  • vesicular monoamine transporter
    • SLC18A1
    • SLC18A2
    • SLC18A3
(19):
  • folate/thiamine transporter
    • SLC19A1
    • SLC19A2
    • SLC19A3
(20):
  • type III Na+-phosphate cotransporter
    • SLC20A1
    • SLC20A2
SLC21–30
(21):
  • Organic anion-transporting polypeptide
    • SLCO1A2
    • SLCO1B1
    • SLCO1B3
    • SLCO1B4
    • SLCO1C1
    • SLCO2A1
    • SLCO2B1
    • SLCO3A1
    • SLCO4A1
    • SLCO4C1
    • SLCO5A1(SLCO6A1)
(22):
  • organic cation/anion/zwitterion transporter
    • SLC22A1
    • SLC22A2
    • SLC22A3
    • SLC22A4
    • SLC22A5
    • SLC22A6
    • SLC22A7
    • SLC22A8
    • SLC22A9
    • SLC22A10
    • SLC22A11
    • SLC22A12
    • SLC22A13
    • SLC22A14
    • SLC22A15
    • SLC22A16
    • SLC22A17
    • SLC22A18
    • SLC22A19
    • SLC22A20
(23):
  • Na+-dependent ascorbic acid transporter
    • SLC23A1
    • SLC23A2
    • SLC23A3
    • SLC23A4
(24):
  • Na+/(Ca2+-K+) exchanger
    • SLC24A1
    • SLC24A2
    • SLC24A3
    • SLC24A4
    • SLC24A5
    • SLC24A6
(25):
  • mitochondrial carrier
    • SLC25A1
    • SLC25A2
    • SLC25A3
    • SLC25A4
    • SLC25A5
    • SLC25A6
    • SLC25A7
    • SLC25A8
    • SLC25A9
    • SLC25A10
    • SLC25A11
    • SLC25A12
    • SLC25A13
    • SLC25A14
    • SLC25A15
    • SLC25A16
    • SLC25A17
    • SLC25A18
    • SLC25A19
    • SLC25A20
    • SLC25A21
    • SLC25A22
    • SLC25A23
    • SLC25A24
    • SLC25A25
    • SLC25A26
    • SLC25A27
    • SLC25A28
    • SLC25A29
    • SLC25A30
    • SLC25A31
    • SLC25A32
    • SLC25A33
    • SLC25A34
    • SLC25A35
    • SLC25A36
    • SLC25A37
    • SLC25A38
    • SLC25A39
    • SLC25A40
    • SLC25A41
    • SLC25A42
    • SLC25A43
    • SLC25A44
    • SLC25A45
    • SLC25A46
(26):
  • multifunctional anion exchanger
    • SLC26A1
    • SLC26A2
    • SLC26A3
    • SLC26A4
    • SLC26A5
    • SLC26A6
    • SLC26A7
    • SLC26A8
    • SLC26A9
    • SLC26A10
    • SLC26A11
(27):
  • fatty acid transport proteins
    • SLC27A1
    • SLC27A2
    • SLC27A3
    • SLC27A4
    • SLC27A5
    • SLC27A6
(28):
  • Na+-coupled nucleoside transport (SLC28A1
    • SLC28A2
    • SLC28A3
(29):
  • facilitative nucleoside transporter
    • SLC29A1
    • SLC29A2
    • SLC29A3
    • SLC29A4
(30):
  • zinc efflux
    • SLC30A1
    • SLC30A2
    • SLC30A3
    • SLC30A4
    • SLC30A5
    • SLC30A6
    • SLC30A7
    • SLC30A8
    • SLC30A9
    • SLC30A10
SLC31–40
(31):
  • copper transporter
    • SLC31A1
(32):
  • Vesicular glutamate transporter 1
    • SLC32A1
(33):
  • Acetyl-CoA transporter
    • SLC33A1
(34):
  • type II Na+-phosphate cotransporter
    • SLC34A1
    • SLC34A2
    • SLC34A3
(35):
  • nucleoside-sugar transporter
    • SLC35A1
    • SLC35A2
    • SLC35A3
    • SLC35A4
    • SLC35A5
    • SLC35B1
    • SLC35B2
    • SLC35B3
    • SLC35B4
    • SLC35C1
    • SLC35C2
    • SLC35D1
    • SLC35D2
    • SLC35D3
    • SLC35E1
    • SLC35E2
    • SLC35E3
    • SLC35E4
(36):
  • proton-coupled amino-acid transporter
    • SLC36A1
    • SLC36A2
    • SLC36A3
    • SLC36A436A2
(37):
  • sugar-phosphate/phosphate exchanger
    • SLC37A1
    • SLC37A2
    • SLC37A3
    • SLC37A4
(38):
  • System A & N, sodium-coupled neutral amino-acid transporter
    • SLC38A1
    • SLC38A2
    • SLC38A3
    • SLC38A4
    • SLC38A5
    • SLC38A6
    • SLC38A10
(39):
  • metal ion transporter
    • SLC39A1
    • SLC39A2
    • SLC39A3
    • SLC39A4
    • SLC39A5
    • SLC39A6
    • SLC39A7
    • SLC39A8
    • SLC39A9
    • SLC39A10
    • SLC39A11
    • SLC39A12
    • SLC39A13
    • SLC39A14
(40):
  • basolateral iron transporter
    • SLC40A1
SLC41–48
(41):
  • Magnesium transporter E
    • SLC41A1
    • SLC41A2
    • SLC41A3
(42):
  • Ammonia transporter
    • RhAG
    • RhBG
    • RhCG
(43):
  • Na+-independent, system-L like amino-acid transporter
    • SLC43A1
    • SLC43A2
    • SLC43A3
(44):
  • Choline-like transporter
    • SLC44A1
    • SLC44A2
    • SLC44A3
    • SLC44A4
    • SLC44A5
(45):
  • Putative sugar transporter
    • SLC45A1
    • SLC45A2
    • SLC54A3
    • SLC45A4
(46):
  • Folate transporter
    • SLC46A1
    • SLC46A2
(47):
  • multidrug and toxin extrusion
    • SLC47A1
    • SLC47A2
(48):
  • Heme transporter
SLCO1–4
  • O1A2
  • O1B1
  • O1B3
  • O2B1
  • O431
  • O4A1
Ion pumps
Symporter, Cotransporter
  • Na+/K+,Cl−
  • Na+/Pi3
  • Na+/Cl−
  • Na+/glucose
  • Na+/I−
  • Cl−/K+
    • 4
    • 5
Antiporter (exchanger)
  • Na+/H+
  • Na+/Ca2+
    • Na+/(Ca2+-K+) - Cl−/HCO−
      3
      (Band 3)
  • Cl−-formate
  • Cl−-oxalate
see also solute carrier disorders
Retrieved from "https://teknopedia.ac.id/w/index.php?title=GLUT2&oldid=1313857824"
Categories:
  • Human genes
  • Solute carrier family
Hidden categories:
  • Articles with short description
  • Short description is different from Wikidata

  • indonesia
  • Polski
  • العربية
  • Deutsch
  • English
  • Español
  • Français
  • Italiano
  • مصرى
  • Nederlands
  • 日本語
  • Português
  • Sinugboanong Binisaya
  • Svenska
  • Українська
  • Tiếng Việt
  • Winaray
  • 中文
  • Русский
Sunting pranala
url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url
Pusat Layanan

UNIVERSITAS TEKNOKRAT INDONESIA | ASEAN's Best Private University
Jl. ZA. Pagar Alam No.9 -11, Labuhan Ratu, Kec. Kedaton, Kota Bandar Lampung, Lampung 35132
Phone: (0721) 702022
Email: pmb@teknokrat.ac.id